08-Jul-2026 16:53:19
SUVEN PHARMA RAISED RS 248.84 CR FUNDS FROM QIB @ ₹134/SHARE
• 1.85 Cr shares allotted at ₹134 per share for ₹248.84 Cr consideration from 17 non-promoter persons/entities. • Paid-up equity share capital increased to ₹28…
Latest market headlines for SUVEN on Terminal.
08-Jul-2026 16:53:19
• 1.85 Cr shares allotted at ₹134 per share for ₹248.84 Cr consideration from 17 non-promoter persons/entities. • Paid-up equity share capital increased to ₹28…
08-Jul-2026 13:11:23
• Allotment of 1,85,70,133 equity shares on preferential basis upon conversion of fully paid warrants. • Total consideration aggregated ₹248,83,97,822/- • Re-a…
17-Jun-2026 12:36:54
Suven Life Sciences announced topline results from its Phase-2b clinical proof-of-concept trial of Ropanicant for Major Depressive Disorder (MDD). Ropanicant 4…
17-Jun-2026 12:18:11
SUVEN LIFE SCIENCES LTD: PROMOTER GROUP CONFIRMS SHARES NOT ENCUMBERED
12-Jun-2026 19:06:10
SUVEN LIFE :Suven Life Sciences announces three poster presentations on Samelisant (SUVN-G3031), including global Phase-3, AWAKE Narcolepsy Study at the SLEEP-…
12-Jun-2026 19:06:10
• 📊 To present 3 scientific posters on Samelisant (SUVN-G3031) at the SLEEP 2026 Annual Meeting in the USA • 🚀 Presentations include the global Phase-3 AWAKE…